Cargando…

Is Development of a Vaccine against Cryptococcus neoformans Feasible?

Detalles Bibliográficos
Autores principales:	Leopold Wager, Chrissy M., Wormley, Floyd L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Pearls
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472670/ https://www.ncbi.nlm.nih.gov/pubmed/26087178 http://dx.doi.org/10.1371/journal.ppat.1004843

Ejemplares similares

Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection
por: Campuzano, Althea, et al.
Publicado: (2017)

Last but not yeast—The many forms of Cryptococcus neoformans
por: Stempinski, Piotr R., et al.
Publicado: (2023)

Balancing Stability and Flexibility within the Genome of the Pathogen Cryptococcus neoformans
por: Ormerod, Kate L., et al.
Publicado: (2013)

IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans
por: Leopold Wager, Chrissy M., et al.
Publicado: (2018)

Cryptococcus and Phagocytes: Complex Interactions that Influence Disease Outcome
por: Leopold Wager, Chrissy M., et al.
Publicado: (2016)

Population Genetic Analyses Reveal the African Origin and Strain Variation of Cryptococcus neoformans var. grubii
por: Litvintseva, Anastasia P., et al.
Publicado: (2012)

Host populations, challenges, and commercialization of cryptococcal vaccines
por: Del Poeta, Maurizio, et al.
Publicado: (2023)

Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice
por: Chaturvedi, Ashok K., et al.
Publicado: (2014)

Induction of Broad-Spectrum Protective Immunity against Disparate Cryptococcus Serotypes
por: Van Dyke, Marley C. Caballero, et al.
Publicado: (2017)

Cryptococcus neoformans Hyperfilamentous Strain Is Hypervirulent in a Murine Model of Cryptococcal Meningoencephalitis
por: Feretzaki, Marianna, et al.
Publicado: (2014)

Development of Protective Inflammation and Cell-Mediated Immunity against Cryptococcus neoformans after Exposure to Hyphal Mutants
por: Zhai, Bing, et al.
Publicado: (2015)

Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis
por: Wozniak, Karen L., et al.
Publicado: (2009)

The Cryptococcus wall: A different wall for a unique lifestyle
por: Mukaremera, Liliane
Publicado: (2023)

Innate Immunity against Cryptococcus, from Recognition to Elimination
por: Campuzano, Althea, et al.
Publicado: (2018)

Cryptococcus and Beyond—Inositol Utilization and Its Implications for the Emergence of Fungal Virulence
por: Xue, Chaoyang
Publicado: (2012)

Immunizing against Anogenital Cancer: HPV Vaccines
por: Pogoda, Cloe S., et al.
Publicado: (2016)

Novel Strategies to Enhance Vaccine Immunity against Coccidioidomycosis
por: Cole, Garry T., et al.
Publicado: (2013)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Protective Immunity Against Cryptococcus Neoformans Infection
por: Schop, Joel
Publicado: (2007)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Pheromone independent unisexual development in Cryptococcus neoformans
por: Gyawali, Rachana, et al.
Publicado: (2017)

CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis
por: Campuzano, Althea, et al.
Publicado: (2020)

Biology must develop herd immunity against bad-actor molecules
por: Plemper, Richard K., et al.
Publicado: (2018)

Interactions between antifungals and everolimus against Cryptococcus neoformans
por: Liang, Pin, et al.
Publicado: (2023)

Environmental Status of Cryptococcus neoformans and Cryptococcus gattii in Colombia
por: Serna-Espinosa, Briggith-Nathalia, et al.
Publicado: (2021)

Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries
por: Otero, Claire E., et al.
Publicado: (2020)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Why HIV Virions Have Low Numbers of Envelope Spikes: Implications for Vaccine Development
por: Schiller, John, et al.
Publicado: (2014)

Tools for Assessing Translation in Cryptococcus neoformans
por: Knowles, Corey M., et al.
Publicado: (2021)

Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence
por: Goswami, Ria, et al.
Publicado: (2020)

Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?
por: Cano, Edison J, et al.
Publicado: (2020)

Cryptococcus neoformans: Tripping on Acid in the Phagolysosome
por: DeLeon-Rodriguez, Carlos M., et al.
Publicado: (2016)

Genetic Diversity and Genomic Plasticity of Cryptococcus neoformans AD Hybrid Strains
por: Li, Wenjun, et al.
Publicado: (2012)

Antifungal potential of punicalagin against Cryptococcus neoformans species complex
por: Silva, Thaísa Cristina, et al.
Publicado: (2018)

Horse: a potential source of Cryptococcus neoformans and Cryptococcus gattii in Egypt
por: Mohammed, Rahma, et al.
Publicado: (2022)

Mechanisms of Dendritic Cell Lysosomal Killing of Cryptococcus
por: Hole, Camaron R., et al.
Publicado: (2012)

Mathematical modeling of pathogenicity of Cryptococcus neoformans
por: Garcia, Jacqueline, et al.
Publicado: (2008)

Central nervous system and Cryptococcus neoformans
por: Gaona-Flores, Veronica A.
Publicado: (2013)

Adaptive Immunity to Cryptococcus neoformans Infections
por: Mukaremera, Liliane, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aigvp2ihltni49g6ufsdbm2of4